National Comprehensive Cancer Network

NCCN Research & Business Resources

NCCN Oncology Research Program (ORP) Recent News

The NCCN Oncology Research Program (ORP) facilitates all phases of clinical research by identifying investigators and initiating clinical trials at NCCN Member Institutions. The NCCN ORP draws on the expertise of investigators at 28 leading cancer centers and establishes collaborations with pharmaceutical and biotechnology companies in order to advance therapeutic options for patients with cancer. To date, the NCCN ORP has provided almost $30 million in research funding to investigators at NCCN Member Institutions. Click on a press release below to learn more about the NCCN ORP.

• NCCN and AstraZeneca Support Quality Improvements for Lung Cancer Care  (05/31/2019)
• NCCN Advances Cancer Research and Oncology Career Development with Young Investigator Awards, Poster Presentations, and Fellows Program  (05/08/2019)
• NCCN Announces Six Quality Improvement Projects in Gastric Cancer Care Approved for Collaboration with Lilly Oncology  (03/20/2019)
• NCCN Awards Grants to Investigators to Study Trifluridine and Tipiracil in Various Cancers  (03/14/2019)
• NCCN Oncology Research Program Awarded $2 Million from Lilly to Study Mechanisms of Resistance to CDK4 & 6 Inhibitors in Breast Cancer Treatment  (12/03/2018)
• NCCN Awarded $2 Million in Research Funding from Taiho Oncology to Study Trifluridine and Tipiracil in Various Cancers  (10/22/2018)

NCCN Oncology Research Program (ORP) News Archive

Please select a year to view our archived press releases:

2019     2018     2017     2016     2015     2014     2013     2012     2011     2010     2009     2008     2007     2006     2005     2003     2002    

For questions about NCCN or to request an interview, please contact Rachel Darwin, darwin@nccn.org.